Convexia
Convexia is an AI-maximalist pharma company that builds autonomous AI agents to scout, vet, and accelerate overlooked drug assets through an end-to-end sourcing and evaluation stack.
About Convexia
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents.
Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico. Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment. Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1. PoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success.
Built by 2 Stanford CS students who have built 3 startups together before.
Products
An end-to-end AI stack for drug sourcing and evaluation featuring modular agents for asset discovery, scientific evaluation, market insight, and operational risk assessment, sup...
A showcase environment demonstrating Convexia's AI agents in action, allowing users to compare tool performance against legacy tools and frontier LLMs in sourcing molecules and...
Security and compliance
No security details published yet
Convexia hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Convexia